Azenta is back in focus as analysts trim their fair value estimate slightly, with the modeled equity value moving from $36.17 to $35.40. Recent Street commentary points to several firms cutting price ...

Why Azenta Is Back On Investors’ Radar Azenta (AZTA) has drawn fresh attention after a volatile stretch, with the share price showing a 1.4% move over the past day, a 10.1% gain over the past month, ...

Azenta (NASDAQ:AZTA) is preparing to release its quarterly earnings on Tuesday, 2024-11-12. Here's a brief overview of what investors should keep in mind before the announcement. Analysts expect ...

Thelema on March 27 informed Azenta that the financing was not in place, according to a filing with the Securities and Exchange Commission. The transaction for B Medical Systems did not close as ...

Azenta, Inc. (NASDAQ:AZTA) is one of the 10 Best Medical Stocks to Buy Under $30. On April 6, Evercore ISI reduced its price ...

"Second quarter results reflect a combination of solid progress on the Services side of the business offset by timing-related issues impacting performance in Products, most notably in B Medical. We ...

Business: Azenta is a life sciences company that operates through two segments. First, there's the life sciences products division, which offers automated cold sample management systems for compound ...

"Our third quarter results reflect positive momentum in both organic revenue growth and profitability. Our go-to-market initiatives continue to gain traction while our cost reduction efforts are ...

Implied volatility shows how much movement the market is expecting in the future. Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big ...

Azenta AZTA shares ended the last trading session 7.2% higher at $49.65. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares ...